Why I Would Buy AstraZeneca plc And TT Electronics plc But Sell Lamprell Plc

Royston Wild explains why investors should — or should not — invest in AstraZeneca plc (LON: AZN), TT Electronics plc (LON: TTG) and Lamprell Plc (LON: LAM).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am looking at the investment case for three London-listed movers.

AstraZeneca

Shares in AstraZeneca (LSE: AZN) (NYSE: AZN.US) have failed to recover from late April’s collapse, the medicines giant’s 2.8% slide today pushing it even further away from last month’s record peak of £48.63p per share. While ongoing worries over further revenues-crushing patent losses is quite rightly stoking investor nerves, I believe that for long-term investors AstraZeneca should prove a lucrative growth pick.

Indeed, AstraZeneca’s R&D operations keep on delivering — the firm expects to start Phase II testing on between 12 and 16 drugs this year, and to receive approval for up to 10 products. On top of this, I reckon that AstraZeneca’s transatlantic lab-building programme, scheduled for completion in 2018, should provide a significant boost to the company’s development profile.

So although AstraZeneca is anticipated to see earnings flatline in 2015, and slip 2% in the following year, I expect its rejuvenated lab operations to drive profits higher once again looking further ahead. And while the pharma play may not be the most jaw-dropping value pick in town — P/E multiples of 16.3 times and 16.5 times for this year and next are just above the benchmark of 15 times which represents decent bang for one’s buck — a prospective dividend of 290 US cents through to the close of 2016 produces a market-beating yield of 4.1%.

TT Electronics

Electronic components play TT Electronics (LSE: TTG) has cheered the market with a positive trading update today and was last dealing 7.3% higher. The Surrey firm advised that it has made “an encouraging start to the year despite the anticipated challenging market conditions,” with its order book remaining strong and overall trading matching expectations. As well, the business advised that its ‘Operational Improvement Plan’ was also on track, with restructuring expected to complete in the first half of 2017.

TT Electronics’ operational footprint covers a wide array of industries, including the aerospace, defence, transportation, industrial and medical sectors. And I believe this diversification should protect its long-term earnings prospects as global growth picks up. Indeed, the number crunchers expect TT Electronics to rebound from an estimated 31% earnings dip this year with a 14% advance in 2016. These figures leave TT Electronics trading on sunny P/E ratios of 14.8 times and 13.1 times for 2015 and 2016 correspondingly.

And the electronics boffins provide excellent value for dividend seekers, too. TT Electronics is expected to keep the dividend on hold around 5.5p per share this year, although a slight hike to 5.6p is chalked in for 2016. As a result the stock carries a mouth-watering 4.2% yield through to the close of next year.

Lamprell

Like TT Electronics, rig builder Lamprell (LSE: LAM) is also performing well in Tuesday business and was recently 2.6% higher. Although company veteran Peter Whitbread announced his departure from the board today, investor sentiment remains upbeat as Lamprell stacks up the contracts — indeed, Abu Dhabi’s National Drilling Company ordered a newbuild rig with the firm in late April.

Although the news has illustrated the benefits of Lamprell’s focus on the Middle East and North Africa, I believe that a backcloth of worsening supply/demand fundamentals in the oil market is likely to constrain spending by the industry’s key players still further in the coming years. This view is shared by the City, and Lamprell is consequently expected to punch a hefty 41% earnings slide in 2015. The bottom line is anticipated to stagnate in 2016.

These figures leave Lamprell changing hands on 12.8 times through to the close of next year, although I would consider a figure closer to the bargain benchmark of 10 times to be a fairer reflection of the risks facing the hardware builder.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »